Quenched Activity-Based Probe Imaging Beneficial in NMSC

Share this content:
Quenched Activity-Based Probe Imaging Beneficial in NMSC
Quenched Activity-Based Probe Imaging Beneficial in NMSC

MONDAY, Jan. 30, 2017 (HealthDay News) -- Quenched activity-based probe imaging can discriminate cancer from normal appearing skin tissue, according to a study published in the February issue of the Journal of the American Academy of Dermatology.

Ethan Walker, M.D., Ph.D., from Case Western Reserve University in Cleveland, and colleagues examined the use of quenched activity-based probe imaging to discriminate cancerous versus normal-appearing skin tissue. They applied the quenched activity-based probe GB119 to non-melanoma skin cancers (NMSCs) excised from 68 patients. Activation of the probe was validated for hematoxylin-eosin-confirmed cancerous tissue versus normal-appearing skin tissue.

The researchers found that the overall estimated sensitivity and specificity were 0.989 (95 percent confidence interval, 0.940 to 1.00) and 0.894 (95 percent confidence interval, 0.769 to 0.965), respectively, for differentiation of basal cell carcinoma and squamous cell carcinoma from normal-appearing skin with topical application of the probe. Compared with conventional hematoxylin-eosin-based pathology, probe activation accurately defined peripheral margins of NMSC.

"These findings merit further studies to determine whether quenched activity-based probe technology may enable cost-effective increased cure rates for patients with NMSC by reducing re-excision and recurrence rates with a rapid and easily interpretable technological advance," the authors write.

Several authors disclosed financial ties to Akrotome Imaging.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Better Stem Cell Tx Outcomes for Younger MS Patients

Better Stem Cell Tx Outcomes for Younger MS ...

Results support additional trials of autologous hematopoietic stem cell transplantation

OD Risk Up in Children Whose Mothers Are Prescribed Opioids

OD Risk Up in Children Whose Mothers Are ...

Second study finds opioids stored unsafely in many households with children

AAP Urges Doctors Not to Punish Pregnant Women for Opioid Use

AAP Urges Doctors Not to Punish Pregnant Women ...

Group says better prevention and treatment, not jail time, would stem surge in drug-addicted newborns

is free, fast, and customized just for you!

Already a member?

Sign In Now »